The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression

INTRODUCTION: P-glycoprotein (P-gp) inhibitors are usually used to treat tumors that overexpress P-gps. However, most common types of breast cancers, such as Luminal A, are low-P-gp expressing, at least during the initial phases of treatment. Therefore, it would be interesting to know if P-gp inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wei, Lin, Zhiqiang, Chen, Meiwan, Yang, Xiucong, Cui, Zheng, Zhang, Xiaofei, Yuan, Lan, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113405/
https://www.ncbi.nlm.nih.gov/pubmed/25092974
http://dx.doi.org/10.2147/IJN.S56070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113405/
https://www.ncbi.nlm.nih.gov/pubmed/25092974
http://dx.doi.org/10.2147/IJN.S56070

Ejemplares similares